TYMS and breast carcinoma: In addition, overexpression of TYMS is closely associated with an unfavorable prognosis for colon cancer [14–16], breast cancer [17], pancreatic cancer [18], cervical cancer [19], non-small cell lung cancer [20], and HCC [21] patients.